GLP-1 receptor agonists like semaglutide reduce appetite and caloric intake through central mechanisms, primarily by acting on the hypothalamus and brainstem. Madsbad, The Lancet Diabetes & Endocrinology Now that we understand the basics, lets explore what makes semaglutide so powerful and potentially game-changing for fitness-focused individuals
Where each stands and what the data shows The reported results put them in a rough order on efficacy, though cross-trial comparisons are not definitive
Key safety information in the Prescribing Information includes: Use in patients with prior pancreatitis: Tirzepatide has not been studied in patients with a history of pancreatitis
Mechanism deep dive: Attia #337 with Ralph DeFronzo, insulin resistance masterclass What this means in practice For most people, the fastest return comes from the lifestyle foundations: (1) movement, (2) fat loss where appropriate, and (3) reducing glucotoxicity
The conversion principle is the same regardless of vial size
